{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:05:21Z","timestamp":1790125521608,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpt.2026.101958","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:12:09Z","timestamp":1788534729000},"page":"101958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Outcomes of Salvage Proton Therapy After Primary Cryosurgery or High-Intensity Focused Ultrasound for Recurrent Localized Prostate Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Daniel A.","family":"Lichlyter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miscia","family":"Fortna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"R.","family":"Charles Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis M.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpt.2026.101958_bib1","unstructured":"National Cancer Instittue Surveillance, Epidemiology, and End Results Program: Cancer Stat Facts - Prostate Cancer. Accessed January 30, 2026. National Institute of HealthAvailable at: https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html."},{"key":"10.1016\/j.ijpt.2026.101958_bib2","first-page":"2351","article-title":"Trends in treatments for prostate cancer in the United States, 2010-2015","volume":"11","author":"Wang","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.ijpt.2026.101958_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102700","article-title":"Prostate cancer incidence rates, trends, and treatment related to prostate-specific antigen screening recommendations in the United States","volume":"93","author":"Merrill","year":"2024","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ijpt.2026.101958_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brachy.2021.06.148","article-title":"Trends and variations in utilization and costs of radiotherapy for prostate cancer: a SEER medicare analysis from 2007 through 2016","volume":"21","author":"Mukherjee","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijpt.2026.101958_bib5","unstructured":"Prostatecomy. Updated October 9, 2022. Accessed January 30, Cleveland Clinic2026. Available at: . https:\/\/my.clevelandclinic.org\/health\/treatments\/24294-prostatectomy."},{"key":"10.1016\/j.ijpt.2026.101958_bib6","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer Version 5.2026 - January 23, National Comprehensive Cancer Network2026. pgs. 1-219. Accessed January 30, 2026. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"10.1016\/j.ijpt.2026.101958_bib7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12672-024-01387-1","article-title":"Trends in focal therapy for localized prostate cancer: a bibliometric analysis from 2014 to 2023","volume":"15","author":"Xia","year":"2024","journal-title":"Discov Oncol"},{"key":"10.1016\/j.ijpt.2026.101958_bib8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1586\/14737140.2014.965687","article-title":"Focal cryotherapy of localized prostate cancer: a systematic review of the literature","volume":"14","author":"Shah","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ijpt.2026.101958_bib9","article-title":"Primary cryotherapy for localised or locally advanced prostate cancer","volume":"5","author":"Jung","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijpt.2026.101958_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijrobp.2015.12.351","article-title":"Proton therapy as salvage treatment for local relapse of prostate cancer following cryosurgery or high-intensity focused ultrasound","volume":"95","author":"Holtzman","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101958_bib11","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.clon.2021.10.012","article-title":"Comparative effectiveness analyses of salvage prostatectomy and salvage radiotherapy outcomes following focal or whole-gland ablative therapy (high-intensity focused ultrasound, cryotherapy or electroporation) for localised prostate cancer","volume":"34","author":"Nathan","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijpt.2026.101958_bib12","unstructured":"Cryotherapy for Prostate Cancer. Accessed January 30, Cancer Research UK2026. Available at: https:\/\/www.cancerresearchuk.org\/about-cancer\/prostate-cancer\/treatment\/cryotherapy."},{"key":"10.1016\/j.ijpt.2026.101958_bib13","article-title":"Systematic review of focal and salvage cryotherapy for prostate cancer","volume":"14","author":"Chin","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ijpt.2026.101958_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/cncr.24779","article-title":"A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer","volume":"116","author":"Donnelly","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijpt.2026.101958_bib15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3109\/02656736.2010.498803","article-title":"High intensity focused ultrasound (HIFU) for prostate cancer: current clinical status, outcomes and future perspectives","volume":"26","author":"Crouzet","year":"2010","journal-title":"Int J Hyperth"},{"key":"10.1016\/j.ijpt.2026.101958_bib16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.eururo.2013.04.039","article-title":"Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients","volume":"65","author":"Crouzet","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijpt.2026.101958_bib17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/JU.0000000000003890","article-title":"Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO Guideline Part III: salvage therapy after radiotherapy or focal therapy, pelvic nodal recurrence and oligometastasis, and future directions","volume":"211","author":"Morgan","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.ijpt.2026.101958_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/jrr\/rrac039","article-title":"Comparing the toxicity and disease control rate of radiotherapy for prostate cancer between salvage settings after high-intensity focused ultrasound therapy and initial settings","volume":"63","author":"Kuroki","year":"2022","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijpt.2026.101958_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semradonc.2020.02.007","article-title":"Proton reirradiation: expert recommendations for reducing toxicities and offering new chances of cure in patients with challenging recurrence malignancies","volume":"30","author":"Simone","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101958_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.euf.2025.02.001","article-title":"Salvage radiotherapy following nonradiotherapy ablative techniques for primary prostate cancer: a systematic review and meta-analysis","volume":"11","author":"Mohamad","year":"2025","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ijpt.2026.101958_bib21","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.20.03282","article-title":"Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial","volume":"39","author":"Murthy","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijpt.2026.101958_bib22","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ijrobp.2025.08.029","article-title":"Androgen deprivation therapy (ADT) and high dose definitive radiotherapy (RT) \u00b1 whole pelvic RT in patients with unfavorable intermediate or favorable high-risk prostate cancer: early results of a phase III randomized controlled trial","volume":"123","author":"Roach","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101958_bib23","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.ijrobp.2018.08.052","article-title":"Short term androgen deprivation therapy without or with pelvic lymph node treatment added to prostate bed only salvage radiotherapy: the NRG Oncology\/RTOG 0534 SPPORT trial","volume":"102","author":"Pollack","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101958_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110665","article-title":"Salvage radiotherapy with volumetric modulated arc therapy (VMAT) for recurrent prostate cancer after high-intensity focused ultrasound (HIFU): a large French retrospective series and literature review","volume":"203","author":"Baude","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijpt.2026.101958_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1028858","article-title":"Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience","volume":"12","author":"Di Lalla","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijpt.2026.101958_bib26","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1038\/s41598-024-59406-8","article-title":"Salvage prostate intensity modulated radiation therapy after cryotherapy failure","volume":"14","author":"Perennec","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijpt.2026.101958_bib27","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1159\/000521660","article-title":"Salvage radiotherapy for recurrent prostate cancer after high-intensity focused ultrasound therapy: quality of life and functional outcome","volume":"106","author":"Cafuta","year":"2022","journal-title":"Urol Int"},{"key":"10.1016\/j.ijpt.2026.101958_bib28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/1754-9485.13384","article-title":"Salvage radiotherapy following HiFU: an institutional series and literature review","volume":"66","author":"Mesci","year":"2022","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101958_bib29","doi-asserted-by":"crossref","first-page":"267-270","DOI":"10.1016\/j.clgc.2020.03.007","article-title":"Early comparative toxicity outcomes of patients with prostate cancer receiving initial cryotherapy and radiotherapy salvage","volume":"19","author":"Jiang","year":"2021","journal-title":"Clin Genitourin Cancer"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S233151802600661X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S233151802600661X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:38:37Z","timestamp":1790123917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S233151802600661X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":29,"alternative-id":["S233151802600661X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101958","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Salvage Proton Therapy After Primary Cryosurgery or High-Intensity Focused Ultrasound for Recurrent Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of Particle Therapy Co-operative Group.","name":"copyright","label":"Copyright"}],"article-number":"101958"}}